These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30399116)

  • 1. Acute Effect of Popular High-Intensity Functional Training Exercise on Physiologic Markers of Growth.
    Kliszczewicz B; Markert CD; Bechke E; Williamson C; Clemons KN; Snarr RL; McKenzie MJ
    J Strength Cond Res; 2021 Jun; 35(6):1677-1684. PubMed ID: 30399116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No evidence of insulin-like growth factor-binding protein 3 proteolysis during a maximal exercise test in elite athletes.
    Dall R; Lange KH; Kjaer M; Jørgensen JO; Christiansen JS; Orskov H; Flyvbjerg A
    J Clin Endocrinol Metab; 2001 Feb; 86(2):669-74. PubMed ID: 11158029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in serum growth hormone (GH)/GH dependent ternary complex components (IGF-I, IGFBP-3, ALS, IGF-I/IGFBP-3 molar ratio) and the influence of these alterations on growth pattern in female rhythmic gymnasts.
    Adiyaman P; Ocal G; Berberoğlu M; Evliyaoğlu O; Aycan Z; Cetinkaya E; Bulca Y; Ersöz G; Akar N
    J Pediatr Endocrinol Metab; 2004 Jun; 17(6):895-903. PubMed ID: 15270408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of physical activity on plasma insulin-like growth factor-1 and insulin-like growth factor binding proteins in healthy older women.
    Chadan SG; Dill RP; Vanderhoek K; Parkhouse WS
    Mech Ageing Dev; 1999 Jun; 109(1):21-34. PubMed ID: 10405986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endurance training-induced changes in the GH-IGF-I axis influence maximal muscle strength in previously untrained men.
    Grandys M; Majerczak J; Kuczek P; Sztefko K; Duda K; Zoladz JA
    Growth Horm IGF Res; 2017 Feb; 32():41-48. PubMed ID: 28017505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise-induced insulin-like growth factor I system concentrations after training in women.
    Gregory SM; Spiering BA; Alemany JA; Tuckow AP; Rarick KR; Staab JS; Hatfield DL; Kraemer WJ; Maresh CM; Nindl BC
    Med Sci Sports Exerc; 2013 Mar; 45(3):420-8. PubMed ID: 23034644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of submaximal exercise on immuno- and bioassayable IGF-I activity in patients with GH-deficiency and healthy subjects.
    Kanaley JA; Frystyk J; Møller N; Dall R; Chen JW; Nielsen SC; Christiansen JS; Jørgensen JO; Flyvbjerg A
    Growth Horm IGF Res; 2005 Aug; 15(4):283-90. PubMed ID: 16027018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of insulin-like growth factor-1 and insulinlike growth factor binding protein-3 in diagnosis of growth hormone deficiency in short-stature children.
    Ali A; Hashim R; Khan FA; Sattar A; Ijaz A; Manzoor SM; Younas M
    J Ayub Med Coll Abbottabad; 2009; 21(3):40-5. PubMed ID: 20929010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: a potential test for GH abuse in sport.
    Wallace JD; Cuneo RC; Baxter R; Orskov H; Keay N; Pentecost C; Dall R; Rosén T; Jørgensen JO; Cittadini A; Longobardi S; Sacca L; Christiansen JS; Bengtsson BA; Sönksen PH
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3591-601. PubMed ID: 10523001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effect of brief low- and high-intensity exercise on circulating insulin-like growth factor (IGF) I, II, and IGF-binding protein-3 and its proteolysis in young healthy men.
    Schwarz AJ; Brasel JA; Hintz RL; Mohan S; Cooper DM
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3492-7. PubMed ID: 8855791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
    Juul A; Kastrup KW; Pedersen SA; Skakkebaek NE
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of neuroendocrinological function by psychosomatic training: acute effect of ChunDoSunBup Qi-training on growth hormone, insulin-like growth factor (IGF)-I, and insulin-like growth factor binding protein (IGFBP)-3 in men.
    Ryu H; Lee MS; Jeong SM; Lee JH; Kang CW; Lee DY; Chung HT
    Psychoneuroendocrinology; 2000 Jul; 25(5):439-51. PubMed ID: 10818279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men.
    Münzer T; Rosen CJ; Harman SM; Pabst KM; St Clair C; Sorkin JD; Blackman MR
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E1006-13. PubMed ID: 16390864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. GH-2000 Study Group.
    Dall R; Longobardi S; Ehrnborg C; Keay N; Rosén T; Jørgensen JO; Cuneo RC; Boroujerdi MA; Cittadini A; Napoli R; Christiansen JS; Bengtsson BA; Sacca L; Baxter RC; Basset EE; Sönksen PH
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4193-200. PubMed ID: 11095453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The growth hormone/insulin-like growth factor-I axis hormones and bone markers in elite athletes in response to a maximum exercise test.
    Ehrnborg C; Lange KH; Dall R; Christiansen JS; Lundberg PA; Baxter RC; Boroujerdi MA; Bengtsson BA; Healey ML; Pentecost C; Longobardi S; Napoli R; Rosén T;
    J Clin Endocrinol Metab; 2003 Jan; 88(1):394-401. PubMed ID: 12519882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
    Khorram O; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women.
    Bowers CY; Granda R; Mohan S; Kuipers J; Baylink D; Veldhuis JD
    J Clin Endocrinol Metab; 2004 May; 89(5):2290-300. PubMed ID: 15126555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chronic treatment with octreotide nasal powder on serum levels of growth hormone, insulin-like growth factor I, insulin-like growth factor binding proteins 1 and 3 in acromegalic patients.
    Invitti C; Fatti L; Camboni MG; Porcu L; Danesi L; Delitala G; Cavagnini F
    J Endocrinol Invest; 1996 Sep; 19(8):548-55. PubMed ID: 8905479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone, insulin growth factor-1, and igf binding protein-3 axis relationship with bone mineral density among healthy men.
    Krassas GE; Papadopoulou P; Koliakos G; Konstantinidis T; Kalothetou K
    Arch Androl; 2003; 49(3):191-9. PubMed ID: 12746097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.